Leflunomide, a novel immunomodulating agent, prevents the development of allergic sensitization in an animal model of allergic asthma

Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
E EberP D Sly

Abstract

Leflunomide is a new anti-inflammatory and immunomodulating agent which is showing promise in several immune disorders, especially rheumatoid arthritis. Its activity profile suggests it may be of use in modulating allergic sensitization. To investigate the effectiveness of leflunomide in preventing the development of allergic sensitization. Fifty-three brown Norway rats were sensitized by intraperitoneal injection of ovalbumin and adjuvant (ricin) on day 0. To determine the ability of leflunomide to inhibit primary allergic sensitization six rats were treated with A77 1726, the active metabolite of leflunomide, from day 0 through day 5, six were treated from day 5 through day 10, and nine rats acted as controls. On day 14, ovalbumin-specific serum antibody levels and the magnitude of the early-phase airway response (EAR) after inhalation allergen challenge were assessed. To determine the ability of acute topical treatment with leflunomide to inhibit mast cell degranulation, three groups of five animals received either vehicle, 100 microg A77 1726, or 1000 g A77 1726 60 min prior to aerosol allergen challenge. To determine the effects of leflunomide treatment in vivo on mast cell function in vitro, mast cells were obtained by br...Continue Reading

References

Jan 1, 1976·International Archives of Allergy and Applied Immunology·S R Smith, J Petillo
Nov 1, 1992·The Journal of Experimental Medicine·P BraddingC H Heusser
Mar 1, 1992·Immunopharmacology·T T GlantR Schleyerbach
Feb 1, 1992·The American Review of Respiratory Disease·J C KipsR A Pauwels
Aug 1, 1990·The American Review of Respiratory Disease·R DjukanovićS T Holgate
Nov 1, 1987·The Journal of Allergy and Clinical Immunology·P H HowarthS T Holgate
Jan 1, 1989·International Journal of Immunopharmacology·G H ThoenesR Schleyerbach
Feb 1, 1989·The Journal of Allergy and Clinical Immunology·M Kaliner
Sep 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J PèneJ Banchereau
May 1, 1988·The American Review of Respiratory Disease·D H EidelmanJ G Martin
Dec 1, 1986·Agents and Actions·S Popovic, R R Bartlett
Dec 1, 1982·The Australian Journal of Experimental Biology and Medical Science·P G HoltJ M Papadimitriou
Oct 1, 1984·The Journal of Experimental Medicine·R H ZublerH R MacDonald
Jun 4, 1981·The New England Journal of Medicine·K A KnauerJ E Fish
Jan 1, 1993·European Journal of Clinical Pharmacology·G MaroneA Genovese
May 1, 1995·International Archives of Allergy and Immunology·B K WershilS J Galli
Sep 1, 1994·American Journal of Respiratory and Critical Care Medicine·C J LanteriP D Sly
Jan 1, 1993·Springer Seminars in Immunopathology·R R BartlettR Schleyerbach
Jan 1, 1993·The American Review of Respiratory Disease·J G MartinW S Powell
Aug 1, 1995·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·T ZielinskiR R Bartlett
Feb 1, 1996·American Journal of Respiratory and Critical Care Medicine·S H LockN C Barnes
Aug 1, 1995·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·H M CherwinskiJ T Ransom
Jul 1, 1995·International Journal of Immunopharmacology·E RubinchikF Levi-Schaffer
Jan 1, 1997·The Journal of Allergy and Clinical Immunology·A G van HalterenG Kraal

❮ Previous
Next ❯

Citations

Oct 3, 1999·Veterinary Immunology and Immunopathology·N C Pedersen
Aug 21, 2004·Hybridoma and Hybridomics·Paulo Henrique Palis AguiarLain Pontes-de-Carvalho
May 29, 2004·Hybridoma and Hybridomics·Paulo Henrique Palis AguiarLain Pontes-de-Carvalho
Jul 24, 1998·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·T UhligP D Sly
May 15, 2013·Expert Opinion on Drug Safety·Helen I KeenSusan E Tett
Oct 30, 2012·The Journal of Allergy and Clinical Immunology·Tea GogishviliThomas Hünig
Nov 6, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Norifumi SawamukaiYoshiya Tanaka

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.